AILatent Spaceabout 2 hours ago
Genesis Molecular AI targets drug discovery with PEARL model
8 min read
Evan Feinberg and Sergey Edunov, a former Llama lead at Meta, founded Genesis Molecular AI. Their PEARL model routinely hits an accuracy threshold needed for real-world drug discovery applications. The company focuses on small molecule drug discovery using diffusion research and co-folding techniques.
Level
Hype check
Tap to vote and see what everyone thinks.
